EP3936142
TRIPLE AGONIST HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS FOR TREATING LIVER DISEASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.6.2020EP published:
17.1.2024EP application number:
20832900.3
EPO information:
European Patent Register
Max expiry date:
28.6.2040
Title in English:
TRIPLE AGONIST HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS FOR TREATING LIVER DISEASELanguage of the patent:
English
Timeline
Today
29.6.2020EP application
17.1.2024EP Publication
Owner
Name:
Hanmi Pharm. Co., Ltd.Address:
214 Muha-ro Paltan-myeon, Hwaseong-si, Gyeonggi-do 18536, KR
Inventor
Name:
KWON, Hyun JooAddress:
Hwaseong-si, Gyeonggi-do 18469, KR
Name:
KIM, Jung KukAddress:
Hwaseong-si, Gyeonggi-do 18469, KR
Name:
PARK, Eun JinAddress:
Hwaseong-si, Gyeonggi-do 18469, KR
Name:
LEE, Jong MinAddress:
Hwaseong-si, Gyeonggi-do 18469, KR
Name:
LEE, Jong SukAddress:
Hwaseong-si, Gyeonggi-do 18469, KR
Name:
JO, Hyo SangAddress:
Hwaseong-si, Gyeonggi-do 18469, KR
Name:
CHOI, In YoungAddress:
Hwaseong-si, Gyeonggi-do 18469, KR
Priority
Number:
20190077776Date:
28.6.2019Country:
KR
Number:
20200004386Date:
13.1.2020Country:
KR
Number:
20200004379Date:
13.1.2020Country:
KR
Number:
20200069219Date:
8.6.2020Country:
KR
Classification
Categories:
A61K 38/17, A61P 1/16, A61K 47/68, A61P 29/00, A61P 35/00